RFA-CA-22-002 - Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics | NOT-CA-22-083 | NCI | Apr 26, 2022 | Dec 31, 2024 | R33, R61, R21, U24, U01 |
| Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology | NOT-CA-22-003 | NCI | Nov 30, 2021 | May 8, 2023 | R03, R61, R33, R21 |
For technical issues E-mail OER Webmaster